American pharmaceutical company Gilead Sciences has set the price of the produced anticanonically drug ramdevpir — $ 390 per bottle. It is reported by CNN.
“A typical five-day course of treatment will consist of six bottles, which will cost USD 2340 per patient,” said Chairman and chief Executive officer of Gilead Sciences Daniel O’day.
The price of one bottle of ramdevpir at $ 390 will act for the government of the United States, hospitals for veterans and the Ministry of defense and the governments of the developed countries.
For private insurance companies in the U.S. the drug will cost $ 520 per bottle, which is 3120 U.S. dollars per patient for a five-day course treatment six bottles.
Ramdevpir, which is currently administered by infusion, is the only drug which received the approval of the office for control over products and medicines of the USA for use in the treatment of coronavirus.